Artia Global Partners »

Atyr Pharma shares owned by Artia Global Partners

Quarter-by-quarter ownership of Atyr Pharma (ATYR) shares owned by Artia Global Partners from 13F filings

Historical chart of Artia Global Partners investment in Atyr Pharma

Tip: Access up to 7 years of quarterly data

All positions including Atyr Pharma held by Artia Global Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atyr Pharma by Artia Global Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $701k 972k 0.72

More positions owned by Artia Global Partners

Insmed Com Par $.01 (INSM)
Argenx Se Sponsored Adr (ARGX)
Soleno Therapeutics (SLNO)
Verona Pharma Sponsored Ads (VRNA)
Uniqure Nv SHS (QURE)
Merus N V (MRUS)
Proshares Tr Ii Ultra Gold (UGL)
Eli Lilly & Co. (LLY)
Vertex Pharmaceuticals Incorporated (VRTX)
Abivax Sa Sponsored Ads (ABVX)
Trevi Therapeutics (TRVI)
Boston Scientific Corporation (BSX)
Alnylam Pharmaceuticals (ALNY)
Quest Diagnostics Incorporated (DGX)
Astrazeneca Sponsored Adr (AZN)

View all positions for Artia Global Partners

Top funds holding Atyr Pharma

FMR
Federated Investors
BlackRock
Vanguard Group
UBS Group
State Street Corporation
Geode Capital Management
Affinity Asset Advisors
Millennium Management
Susquehanna International
Rosalind Advisors
Artia Global Partners
Jane Street
Citadel Advisors
GSA Capital Partners

View all funds holding Atyr Pharma